Compare Colgate-Palmolive Company (CL) vs Goldman Sachs Group Inc (GS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Colgate-Palmolive Company vs Goldman Sachs Group Inc — how do they compare? Colgate-Palmolive Company trades at $90.95 (market cap $72.84B), while Goldman Sachs Group Inc trades at $1,144 (market cap $336.31B). The key difference: Goldman Sachs Group Inc is far larger — about 4.6× Colgate-Palmolive Company's market cap, and Colgate-Palmolive Company pays the higher dividend (2.33%). Which is the better fit depends on your goals.
| CL | GS | |
|---|---|---|
Market Cap | $72.84B | $336.31B |
Sector | Consumer Staples | Financials |
52-Week High | $99.14 | $1.14K |
52-Week Low | $74.98 | $700.41 |
Enterprise Value | $79.48B | — |
Dividend Yield | 2.33% | 1.58% |
Volume | — | 2,592,735 |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Colgate-Palmolive (CL) trades at $93.21, up 1.05% with a bullish technical signal and consistent earnings beats. The stock shows strong profitability with 60.06% gross margins and 822.05% ROE, though valuation metrics appear elevated with a P/E of 36.13. Recent dividend declarations and positive analyst coverage (42% buy rating) support the defensive stock's appeal amid market rotation into stable cash flow names.
Outlook remains positive with a $97 consensus price target representing 4% upside, though premium valuation and North American segment softness present headwinds. The company's 64-year dividend growth streak and global diversification provide stability, while inflation pressures and competitive threats require monitoring for sustained outperformance.
Goldman Sachs (GS) trades at $1,140, up 8.04% in the past 24 hours, with a bullish technical outlook and strong earnings momentum after beating EPS estimates for three consecutive quarters. The stock shows robust fundamentals with a 29.89% net income margin and 15.69% ROE, supported by positive analyst sentiment and involvement in high-profile IPOs like Anthropic. Revenue growth accelerated to $58.28 billion in 2025, though cash flow trends remain volatile.
The outlook for GS is positive, driven by investment banking strength and AI-driven IPO opportunities, but risks include negative operating cash flows and elevated debt levels. Analysts maintain a consensus price target of $1,080, with 40% recommending Buy. Investors should weigh the company's profit growth against liquidity concerns and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Colgate-Palmolive Company
Since its founding in 1806, Colgate-Palmolive has grown to become a leading global consumer product company. In addition to its namesake oral care line, the firm manufactures shampoos, shower gels, deodorants, and home care products that are sold in over 200 countries (international sales account for about 70% of its consolidated total, including approximately 45% from emerging regions). It also owns specialty pet food maker Hill's, which sells its products through veterinarians and specialty pet retailers.
Read more on CL →About Goldman Sachs Group Inc
The Goldman Sachs Group, Inc., a bank holding company, is a global investment banking and securities firm specializing in investment banking, trading and principal investments, asset management and securities services. The Company provides services to corporations, financial institutions, governments, and high-net worth individuals.
Read more on GS →
